All practice questions

4736 questions

Question 4381Question →

During a comprehensive intake evaluation at a new primary care practice, a physician assesses a 61-year-old male patient who has lacked medical follow-up for the past eight years. His past medical history includes type 2 diabetes mellitus, currently managed with diet and metformin. The patient reports a history of smoking one pack of cigarettes daily starting at age 20, but he successfully quit 11 years ago and has abstained since. He denies alcohol or recreational drug use. Blood pressure is 128/82 mmHg, and body mass index is 28 kg/m². A recent basic metabolic panel and hemoglobin A1c (6.7%) are stable. The physician is planning his health maintenance schedule. Which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Annual screening for lung cancer with low-dose computed tomography; Administration of the 20-valent pneumococcal conjugate vaccine; Administration of the recombinant zoster vaccine

Answer

The indicated interventions are annual low-dose computed tomography of the chest, the 20-valent pneumococcal conjugate vaccine, and the recombinant zoster vaccine.
This patient meets the precise criteria for three distinct preventive interventions based on current evidence-based guidelines. First, he requires annual lung cancer screening with a low-dose CT scan because he falls in the 50-80 age range, has a 30 pack-year smoking history (exceeding the 20 pack-year threshold), and quit less than 15 years ago (11 years ago). Second, he requires the 20-valent pneumococcal conjugate vaccine; although he is under 65, his diagnosis of diabetes mellitus places him in the high-risk group of 19-to-64-year-olds who require early vaccination. Third, he requires the recombinant zoster vaccine, which is universally recommended as a two-dose series for all adults aged 50 and older regardless of prior chickenpox history.

Step-by-Step Solution

1
Analyze the patient's smoking history against lung cancer screening guidelines.
The patient is 61 years old, has a 30 pack-year smoking history, and quit 11 years ago.
This meets the USPSTF criteria for low-dose CT screening, which targets adults aged 50 to 80 with at least a 20 pack-year history who smoke or quit within the last 15 years.
2
Evaluate the patient's immunization needs based on age and specific comorbidities.
The patient requires the recombinant zoster vaccine and the 20-valent pneumococcal conjugate vaccine.
The zoster vaccine is universally recommended for adults over 50. While universal pneumococcal vaccination begins at age 65, this patient qualifies early (age 19-64 bracket) due to his diabetes mellitus.
3
Assess the patient's eligibility for abdominal aortic aneurysm (AAA) screening.
The patient does not currently meet the criteria for AAA screening.
Although he is a male with a history of smoking, AAA screening is strictly recommended starting at age 65.
4
Determine the appropriate formulation for the annual influenza vaccine.
The intranasal live-attenuated influenza vaccine cannot be administered.
The live-attenuated vaccine is restricted to healthy individuals aged 2 through 49 years and is generally avoided in those with underlying chronic conditions such as diabetes.

Key Concept

Application of age- and comorbidity-specific preventive care guidelines for cancer screening and adult immunizations.
Question 4382Question →

A hospital quality improvement committee is designing a prospective intervention study to reduce catheter-associated urinary tract infections (CAUTIs) in the intensive care unit. They plan to compare a new silver-alloy catheter to the standard silicone catheter. A priori power analysis determines that 108 patients per intervention group are required to achieve a statistical power of 80%80\% (β=0.20\beta = 0.20) at a significance level of α=0.05\alpha = 0.05 to detect a clinically meaningful reduction in CAUTI incidence. Based on prior hospital initiatives, the committee anticipates a 20%20\% loss of analyzable data due to early patient transfers or incomplete electronic health records.

To ensure the study maintains the desired 80%80\% power, what is the minimum total number of patients the committee must initially enroll across both groups combined?

Show answer & explanation

Answer: 270

Answer

270
Statistical power heavily relies on the final number of subjects analyzed at the conclusion of a study. If an a priori power calculation determines that 108 patients are required per group, and a 20%20\% dropout rate is expected, enrolling exactly 108 patients would result in only ≈86\approx 86 analyzable patients per arm. This severely diminishes the study's power and substantially increases the risk of a Type II error (failing to detect a true difference). To ensure the final analyzed sample meets the target for robust statistical power, the initial enrollment per group must account for this loss using the formula: Nenrolled=Nneeded1−attrition rateN_{enrolled} = \frac{N_{needed}}{1 - \text{attrition rate}}. For this study, Nenrolled=1081−0.20=1080.80=135N_{enrolled} = \frac{108}{1 - 0.20} = \frac{108}{0.80} = 135 patients per group. Because the trial compares two groups (a new silver-alloy catheter and a standard silicone catheter), the total minimum enrollment required across both arms combined is 135×2=270135 \times 2 = 270 patients.

Step-by-Step Solution

1
Identify the target final sample size and anticipated attrition rate.
Target = 108 patients per group; Attrition = 20% (0.20).
These specific variables are required to accurately adjust the initial enrollment target upward.
2
Calculate the required initial enrollment per group.
108 / (1 - 0.20) = 135 patients per group.
Dividing the required final size by the proportion of patients expected to complete the study ensures that, after attrition, the group still contains 108 patients.
3
Calculate the total required enrollment across the entire study.
135 patients/group * 2 groups = 270 patients.
The study compares two separate groups (silver-alloy vs. standard catheter). Therefore, the calculated per-group enrollment must be multiplied by 2.

Key Concept

To maintain statistical power despite anticipated patient dropout or data loss, the initial enrollment target per study arm must be calculated as: Required Sample Size / (1 - Attrition Rate).
Question 4383Question →

A 31-year-old male architect presents to the infectious disease clinic to discuss the results of recent blood work. He recently tested positive for HIV, and subsequent flow cytometry revealed a CD4 T-lymphocyte count of 410 cells/mm3410 \text{ cells/mm}^3. The physician advises starting a daily antiretroviral regimen. The patient shakes his head and states, "I run marathons and have never felt better. I saw on a forum that these drugs destroy your liver and cause horrible fatigue. There is no way I am starting them until I actually feel ill." Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: It is understandable to be concerned about potential adverse effects. What other information have you read regarding these treatments?

Answer

The most appropriate initial response is to validate the patient's concerns and ask an open-ended question to further explore his understanding regarding the treatments.
The correct answer demonstrates patient-centered communication by validating the patient's emotions and utilizing an open-ended question. In patients expressing hesitancy or resistance based on external information, the initial step should always be to non-judgmentally explore their health beliefs. This builds a therapeutic alliance and helps the physician understand the exact nature of the misconception before attempting to provide medical facts or strong recommendations.

Step-by-Step Solution

1
Analyze the clinical scenario.
A newly diagnosed, asymptomatic HIV patient is refusing highly recommended antiretroviral therapy due to fears of medication toxicity based on internet research.
Identifying the root cause of the patient's hesitancy is critical for determining the next counseling step.
2
Identify the primary goal of the physician at this moment.
The physician must establish a therapeutic alliance and address the patient's specific health beliefs without being confrontational.
Effective patient education requires a collaborative, non-judgmental environment rather than immediate lecturing.
3
Evaluate the response strategies in the options.
Correcting facts prematurely, threatening capacity evaluations, or citing legal reporting requirements will likely cause the patient to become defensive and withdraw from care.
These approaches hinder open communication and violate the principles of motivational interviewing.
4
Select the best statement.
Choose the response that validates his feelings ('It is understandable to be concerned...') and invites further dialogue ('What other information have you read...?').
This empathetic approach fosters trust and provides the physician with the necessary context to tailor subsequent health education.

Key Concept

Patient-centered communication and motivational interviewing principles when addressing medication hesitancy.
Question 4384Question →

A physician is training medical residents on the use of Motivational Interviewing (MI) techniques for lifestyle modification counseling. The core skills of MI are often summarized by the acronym OARS. Match each of the physician's verbal statements provided below with the specific MI communication technique it best represents.

Click a left item, then click its matching right item

Items

"How do you feel your current smoking habits are affecting your daily asthma symptoms?"
"It takes a lot of determination to come in today and discuss your weight, knowing it is a difficult topic for you."
"From what you are saying, you feel frustrated because you are trying to diet, but the stress at work makes it hard to resist snacking."
"Let me make sure I understand everything we discussed: you are concerned about your blood pressure, you have agreed to try walking for 20 minutes a day, and we will check back in two weeks."

Matches

Show answer & explanation

Answer

Statement 1 matches Open-ended inquiry, Statement 2 matches Affirmation, Statement 3 matches Reflective listening, and Statement 4 matches Summarization.
Motivational Interviewing utilizes the OARS core skills to elicit behavior change and explore ambivalence. Open-ended questions encourage the patient to do most of the talking. Affirmations build patient confidence and acknowledge the difficulty of change. Reflections show empathy and an understanding of the patient's perspective, helping them hear their own thoughts. Summaries pull together important points of the consultation to confirm understanding and form a cohesive plan.

Step-by-Step Solution

1
Analyze the first statement to identify its communication purpose.
The statement asks a question requiring more than a yes/no answer to explore the patient's perspective.
This defines an Open-ended inquiry, the 'O' in OARS.
2
Analyze the second statement.
The statement highlights a positive trait (determination) and validates the patient's effort.
This defines an Affirmation, the 'A' in OARS.
3
Analyze the third statement.
The statement restates the patient's feelings and situational context to show understanding without adding new meaning.
This defines Reflective listening, the 'R' in OARS.
4
Analyze the fourth statement.
The statement gathers the main points of the entire visit into a cohesive review.
This defines Summarization, the 'S' in OARS.

Key Concept

Motivational Interviewing core communication skills (OARS)
Question 4385Question →

A 62-year-old woman is evaluated in the intensive care unit for persistent oozing from her intravenous catheter sites. She was admitted two days ago with sepsis secondary to ascending cholangitis. She has a history of primary biliary cholangitis and cirrhosis. Current medications include broad-spectrum intravenous antibiotics and vasopressors. Vital signs show a temperature of 38.2∘C38.2^\circ\text{C}, blood pressure of 90/55 mmHg90/55\text{ mmHg}, and heart rate of 110/min110/\text{min}. Laboratory studies show:

Laboratory ParameterPatient ValueReference Range
Platelet count65,000/mm365,000/\text{mm}^3150,000−400,000/mm3150,000 - 400,000/\text{mm}^3
Prothrombin time (PT)24 s24\text{ s}11−15 s11 - 15\text{ s}
Activated partial thromboplastin time (aPTT)58 s58\text{ s}25−40 s25 - 40\text{ s}
Fibrinogen130 mg/dL130\text{ mg/dL}150−400 mg/dL150 - 400\text{ mg/dL}
Factor V activity25%25\%70%−130%70\% - 130\%
Factor VII activity20%20\%70%−130%70\% - 130\%
Factor VIII activity210%210\%50%−150%50\% - 150\%

Based on these findings, which of the following is the most likely primary cause of this patient's coagulopathy?

Show answer & explanation

Answer: Severe hepatic synthetic dysfunction

Answer

Severe hepatic synthetic dysfunction
The correct answer accurately identifies severe hepatic synthetic dysfunction as the cause. The key differentiating laboratory value is Factor VIII. The liver synthesizes almost all coagulation factors, including Factor V and Factor VII, which are appropriately low in this patient due to her underlying cirrhosis and acute decompensation. However, Factor VIII is synthesized by endothelial cells throughout the body and functions as an acute-phase reactant. Therefore, in severe liver disease, Factor VIII levels are typically normal or highly elevated (as seen here).

Step-by-Step Solution

1
Evaluate the clinical context and initial lab pattern.
The patient has cirrhosis and sepsis with oozing, prolonged PT/aPTT, thrombocytopenia, and low fibrinogen. This pattern can be seen in both severe liver disease and DIC.
Establishing the differential diagnosis for generalized coagulopathy in a critically ill patient is the first required step.
2
Analyze the specific coagulation factor assays.
Factor V and Factor VII are significantly decreased, whereas Factor VIII is markedly elevated at 210%.
Specific factor levels are required to differentiate the exact mechanism of the coagulopathy when screening tests overlap.
3
Correlate factor levels with underlying pathophysiology.
The liver synthesizes Factors V and VII, explaining their low levels in hepatic failure. Crucially, Factor VIII is synthesized by endothelial cells and acts as an acute-phase reactant, so it remains elevated in liver disease but is consumed (and therefore low) in DIC.
Understanding the cellular origin and systemic behavior of Factor VIII definitively distinguishes hepatic synthetic dysfunction from consumptive coagulopathy.

Key Concept

In complex coagulopathies, Factor VIII activity differentiates liver disease (normal/elevated) from disseminated intravascular coagulation (low).
Question 4386Question →

A 54-year-old man presents to the clinic to establish care. He has not seen a physician in five years. His medical history includes type 2 diabetes mellitus, hypertension, and stage 3a chronic kidney disease. Current medications include lisinopril, amlodipine, metformin, and empagliflozin. He smoked 1.5 packs of cigarettes daily from age 18 until he quit at age 48. His family history is notable for a father who was diagnosed with colorectal cancer at age 65. The patient's last colonoscopy was at age 49 and showed no polyps. He received an annual influenza vaccine at a local pharmacy three weeks ago. His tetanus-diphtheria-acellular pertussis (Tdap) vaccination is up to date, and he completed the hepatitis B vaccine series in his 30s. He has never received a pneumococcal vaccine or a zoster vaccine. Which of the following combinations of preventive interventions is most appropriate for this patient today?

Show answer & explanation

Answer: Administer the 20-valent pneumococcal conjugate vaccine (PCV20) and order a low-dose chest CT

Answer

Administer the 20-valent pneumococcal conjugate vaccine (PCV20) and order a low-dose chest CT
The correct answer accurately identifies that the patient requires lung cancer screening and an updated pneumococcal vaccination. The USPSTF recommends annual low-dose chest CT (LDCT) for adults aged 50-80 years who have at least a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This 54-year-old patient has a 45 pack-year history and quit 6 years ago, making LDCT strongly indicated. Furthermore, ACIP guidelines recommend that adults aged 19-64 years with certain underlying medical conditions (including diabetes and chronic kidney disease) who have not previously received a pneumococcal conjugate vaccine should receive a single dose of PCV20 (or a dose of PCV15 followed by PPSV23). Therefore, administering PCV20 and ordering a LDCT are both indicated today.

Step-by-Step Solution

1
Calculate smoking pack-years and verify lung cancer screening eligibility.
The patient smoked 1.5 packs/day for 30 years (45 pack-years) and quit 6 years ago. At age 54, he meets criteria for annual low-dose chest CT (LDCT).
USPSTF recommends LDCT for adults 50-80 with a ≥20 pack-year history who currently smoke or quit within the past 15 years.
2
Determine appropriate pneumococcal vaccination based on medical history.
The patient is under 65 but has diabetes and chronic kidney disease, making him eligible for pneumococcal vaccination. As a vaccine-naive adult, he should receive PCV20.
Current ACIP guidelines recommend a single dose of PCV20 (or PCV15 followed by PPSV23) for adults 19-64 with risk factors.
3
Evaluate the need for colorectal cancer screening based on family history.
His father was diagnosed at age 65 (≥60 years old). His screening began before 50, but the surveillance interval remains 10 years following a normal exam. His last was at age 49, so the next is due at 59.
Ensures adherence to interval guidelines and prevents unnecessary invasive testing.
4
Check eligibility for abdominal aortic aneurysm (AAA) screening.
The patient is 54 years old, which is too young for AAA screening.
USPSTF recommends one-time AAA screening with ultrasound only for men aged 65-75 who have ever smoked.

Key Concept

Integration of age-specific, risk-specific, and family history-based guidelines for preventive screening and immunizations in adults.
Question 4387Question →

A 61-year-old postmenopausal woman presents to the ambulatory clinic for an annual wellness visit. She has not seen a physician in three years. Medical history is significant for mild hypertension and gastroesophageal reflux disease. Current medications include amlodipine and pantoprazole. Social history is notable for smoking 10 cigarettes a day (25-pack-year history) and drinking 1-2 glasses of wine on weekends. Her mother suffered a femoral neck fracture at age 76. Her preventive care history includes a normal screening mammogram and normal cervical cytology with human papillomavirus (HPV) co-testing one month ago at a health fair. Her last screening colonoscopy was normal at age 55. Physical examination reveals a blood pressure of 128/82 mm Hg, heart rate of 72/min, and a body mass index (BMI) of 22 kg/m². The remainder of the examination is unremarkable. The patient asks if she should be tested for osteoporosis. According to current guidelines, which of the following is the most appropriate next step regarding osteoporosis screening for this patient?

Show answer & explanation

Answer: Calculate fracture risk using a formal clinical risk assessment tool

Answer

Calculate fracture risk using a formal clinical risk assessment tool
The United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing (e.g., DEXA) in all women aged 65 and older. For postmenopausal women younger than 65, screening is indicated only if they are at increased risk for osteoporotic fractures. Crucially, this risk must be determined using a formal clinical risk assessment tool, such as the Fracture Risk Assessment Tool (FRAX), the Osteoporosis Risk Assessment Instrument (ORAI), or the Osteoporosis Self-Assessment Tool (OST). This patient has multiple risk factors (smoking, parental hip fracture, lower BMI), but the evidence-based next step is to quantify her risk using a validated tool to see if it meets the screening threshold (equivalent to the risk of a 65-year-old white woman without major risk factors, which is approximately 8.4%). Only if her calculated risk meets or exceeds this threshold should a DEXA scan be ordered.

Step-by-Step Solution

1
Assess the patient's demographic and menopausal status
The patient is a 61-year-old postmenopausal woman.
Osteoporosis screening guidelines differ significantly based on whether a woman is over or under the age of 65.
2
Identify relevant clinical risk factors for osteoporosis
Risk factors include current smoking, parental history of hip fracture, lower body mass index (22 kg/m²), and chronic proton pump inhibitor use (pantoprazole).
The presence of clinical risk factors in a woman under 65 indicates a potential need for earlier screening.
3
Apply the USPSTF screening guidelines for women under 65 years of age
Guidelines recommend screening postmenopausal women under 65 only if their 10-year fracture risk meets or exceeds 8.4%, which must be calculated by a formal clinical risk assessment tool.
A formal tool (e.g., FRAX) must be used to objectively quantify risk before proceeding with bone measurement testing.

Key Concept

In postmenopausal women younger than 65 years, osteoporosis screening with DEXA is indicated only if a formal clinical risk assessment tool demonstrates a 10-year fracture risk equal to or greater than that of a 65-year-old white woman with no additional risk factors (≥ 8.4%).
Estimated Time:1m 30s
Question 4388Question →

An attending physician is evaluating a hospitalized patient who has developed worsening lower extremity edema and frothy urine. Initial laboratory studies reveal a serum albumin level of 1.51.5 g/dL. A basic metabolic panel is obtained concurrently, which demonstrates a measured total serum calcium level of 6.86.8 mg/dL. Assuming a standard reference albumin value of 4.04.0 g/dL for calculation purposes, what is this patient's corrected total serum calcium concentration?

Show answer & explanation

Answer: 8.8

Answer

The corrected total serum calcium concentration is 8.8 mg/dL.
The correct calculation yields 8.8 mg/dL. Approximately 40% to 45% of total serum calcium is bound to plasma proteins, primarily albumin. When albumin levels are significantly reduced (such as in nephrotic syndrome), the measured total calcium drops accordingly. However, the physiologically active ionized calcium generally remains normal. To avoid erroneously diagnosing true hypocalcemia (pseudohypocalcemia), the measured total calcium must be corrected by adding 0.8 mg/dL for every 1.0 g/dL decrease in serum albumin below the standard reference of 4.0 g/dL. In this patient, the albumin deficit is 2.5 g/dL, resulting in an upward correction of 2.0 mg/dL to the measured 6.8 mg/dL.

Step-by-Step Solution

1
Extract the given laboratory values from the clinical vignette.
Measured calcium = 6.86.8 mg/dL, Albumin = 1.51.5 g/dL.
These core variables are required to adjust total calcium for hypoalbuminemia.
2
Determine the difference between the standard reference albumin and the patient's albumin.
4.0−1.5=2.54.0 - 1.5 = 2.5 g/dL.
To calculate the correction factor, we must first quantify how much the albumin has decreased from the normal baseline.
3
Calculate the calcium correction factor.
2.5×0.8=2.02.5 \times 0.8 = 2.0 mg/dL.
For every 1.01.0 g/dL decrease in serum albumin below 4.04.0, total serum calcium decreases by approximately 0.80.8 mg/dL due to reduced protein binding.
4
Add the correction factor to the measured total calcium.
6.8+2.0=8.86.8 + 2.0 = 8.8 mg/dL.
This yields the corrected total calcium, which accurately reflects the patient's physiologically active ionized calcium status.

Key Concept

Correcting total serum calcium in the setting of hypoalbuminemia to distinguish true hypocalcemia from pseudohypocalcemia.
Estimated Time:1m 0s
Question 4389Question →

A primary care network is planning a randomized controlled trial to evaluate a novel pharmacist-led telehealth coaching program. The goal is to reduce systolic blood pressure among adult patients with uncontrolled hypertension. The primary outcome is the mean change in systolic blood pressure at 6 months. Preliminary calculations indicate the study will have 70% power to detect a 4 mmHg4\text{ mmHg} difference between the intervention and standard care groups, assuming a standard deviation of 12 mmHg12\text{ mmHg} and a two-sided significance level (α\alpha) of 0.05. The trial steering committee dictates that the statistical power must be at least 80% before recruitment begins. Which of the following modifications to the trial design or statistical plan would individually increase the statistical power of the study? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Enrolling a larger total number of participants by extending the recruitment period; Modifying the inclusion criteria to select a patient cohort with a lower expected standard deviation in baseline blood pressure

Answer

The trial's statistical power can be increased by enrolling a larger total number of participants and by modifying inclusion criteria to select a cohort with a lower expected standard deviation.
Statistical power is the likelihood that a study will detect an effect when there is an effect there to be detected. It mathematically depends on four primary factors: sample size, effect size, variance (standard deviation), and the significance level (α\alpha). Expanding the recruitment period to enroll more patients directly increases the sample size. Modifying inclusion criteria to select a cohort with a lower baseline standard deviation decreases the variance in the data. Both of these modifications make it statistically easier to detect a true 4 mmHg4\text{ mmHg} difference, thereby increasing the study's power.

Step-by-Step Solution

1
Identify the components that determine statistical power in a continuous outcome trial.
Power (1−β1 - \beta) is influenced by sample size (nn), effect size (Δ\Delta), significance level (α\alpha), and standard deviation (σ\sigma).
Understanding the mathematical relationships between these variables is necessary to determine which modifications will increase power.
2
Evaluate the effect of changing sample size.
Increasing the number of participants (nn) narrows the standard error of the mean, making it easier to detect a true difference.
Larger sample sizes yield a higher probability of rejecting a false null hypothesis.
3
Evaluate the effect of changing the standard deviation.
Decreasing the standard deviation (σ\sigma) by selecting a more homogenous cohort reduces data spread, which increases power.
Less noise in the data makes the true signal (effect size) easier to detect.
4
Analyze the incorrect design modifications.
Converting continuous data to categorical data, stratifying without increasing sample size, and focusing on predictive value all fail to increase or actively decrease statistical power.
These actions either discard information, reduce available sample size per group, or affect parameters unrelated to the calculation of statistical power.

Key Concept

Statistical power (1−β1 - \beta) can be increased by increasing the sample size, increasing the effect size, increasing the alpha level, or decreasing the variance (standard deviation) of the outcome.
Estimated Time:1m 30s
Question 4390Question →

Match each adult patient presenting for a health maintenance or prenatal visit with the most appropriate next step in preventive care based on current guidelines.

Click a left item, then click its matching right item

Items

A 42-year-old asymptomatic man whose paternal uncle was diagnosed with colon cancer at age 55.
A 68-year-old man with a 25 pack-year smoking history who quit smoking at age 45.
A 28-year-old pregnant woman at 28 weeks gestation who received a Tdap vaccine during her previous pregnancy 2 years ago.
A 45-year-old woman who underwent mantle field radiation therapy for Hodgkin lymphoma at age 25.

Matches

Show answer & explanation

Answer

The 42-year-old man requires average-risk colon cancer screening at age 45; the 68-year-old former smoker requires an AAA ultrasound; the pregnant woman requires a Tdap vaccine now; the Hodgkin lymphoma survivor requires annual breast MRI and mammography.
Each patient presentation contains specific historical details—such as the degree of family relation, years since quitting smoking, current pregnancy status, and prior chest radiation—that trigger specific algorithms within established preventive care guidelines.

Step-by-Step Solution

1
Evaluate the 42-year-old man's family history for colon cancer risk.
He has a single second-degree relative affected at age 55, placing him at average risk.
High-risk screening requires a first-degree relative with colorectal cancer or advanced adenoma. Therefore, average-risk guidelines apply, meaning screening starts at age 45.
2
Assess the 68-year-old former smoker for lung and vascular screening eligibility.
He qualifies for an abdominal aortic aneurysm (AAA) ultrasound but not low-dose CT (LDCT) for lung cancer.
He is a man aged 65-75 who has smoked more than 100 cigarettes (qualifying for one-time AAA screening), but he quit 23 years ago, exceeding the 15-year limit for LDCT eligibility.
3
Determine the Tdap vaccine indication for the pregnant patient.
She should receive the Tdap vaccine at this 28-week visit.
Acellular pertussis vaccination is required during every pregnancy (optimally between 27 and 36 weeks) to maximize passive antibody transfer to the fetus, regardless of the patient's previous vaccination doses.
4
Identify appropriate breast cancer screening for a Hodgkin lymphoma survivor.
She requires both annual mammography and breast MRI.
Chest radiation between ages 10 and 30 significantly increases breast cancer risk, warranting aggressive screening with both modalities.

Key Concept

Nuances of USPSTF and ACIP guidelines regarding family history, smoking cessation timelines, pregnancy, and prior radiation exposure.
Question 4391Question →

Four adult patients hospitalized with respiratory symptoms undergo thoracentesis for newly discovered pleural effusions. Based on Light's criteria and the accompanying specialized fluid analyses, match each patient's pleural fluid (PF) profile to the most likely underlying etiology.

Click a left item, then click its matching right item

Items

PF/Serum Protein: 0.30.3, PF/Serum LDH: 0.40.4, PF WBC: 400/μL400/\mu L
PF/Serum Protein: 0.80.8, PF/Serum LDH: 0.80.8, PF Glucose: 2020 mg/dL, PF WBC: 45,000/μL45,000/\mu L, pH: 6.96.9
PF/Serum Protein: 0.70.7, PF/Serum LDH: 0.90.9, PF WBC: 1,500/μL1,500/\mu L (85%85\% lymphocytes), Adenosine deaminase (ADA): 5555 U/L
PF/Serum Protein: 0.60.6, PF/Serum LDH: 0.70.7, PF Glucose: 1515 mg/dL, Rheumatoid factor: positive

Matches

Show answer & explanation

Answer

The transudative profile matches heart failure; the purulent, low-pH profile matches empyema; the lymphocytic profile with elevated ADA matches tuberculous pleurisy; and the exudative profile with extremely low glucose matches rheumatoid arthritis-associated effusion.
Correct matching requires sequential application of Light's criteria to separate transudates (heart failure) from exudates (empyema, TB, rheumatoid arthritis), followed by interpretation of specific fluid markers (pH, ADA, cell counts, RF) to distinguish among the exudative etiologies.

Step-by-Step Solution

1
Apply Light's criteria to each pleural fluid profile.
The first profile is a transudate (protein ratio ≤0.5\le 0.5, LDH ratio ≤0.6\le 0.6). The other three profiles are exudates.
Differentiating transudates from exudates narrows down the underlying pathophysiologic mechanism (hydrostatic/oncotic versus inflammatory/malignant).
2
Identify the cause of the transudative effusion.
The transudative fluid is matched with heart failure exacerbation.
Heart failure causes fluid accumulation via increased pulmonary capillary hydrostatic pressure, without capillary leakage of large proteins or LDH.
3
Analyze the specific biochemical markers in the three exudative fluids.
The high-neutrophil/low-pH fluid indicates bacterial infection (empyema). The high-lymphocyte/high-ADA fluid indicates tuberculosis. The low-glucose/RF-positive fluid indicates rheumatoid pleuritis.
While exudates share similar Light's criteria, specific markers like cell differential, pH, glucose, and specialized tests (ADA, RF) allow for precise etiologic diagnosis.

Key Concept

Interpretation of pleural fluid using Light's criteria and etiology-specific biochemical markers.
Estimated Time:1m 0s
Question 4392Question →

A physician is evaluating a 46-year-old man during a routine wellness examination. The patient's past medical history is significant for pancolonic ulcerative colitis diagnosed 12 years ago. His gastrointestinal disease is currently in deep clinical remission, maintained solely on scheduled infliximab infusions. He reports smoking one pack of cigarettes daily for the past 25 years. Due to a prolonged period of uninsurance, he has not undergone any preventive health screenings or received any immunizations over the past decade. Today, he feels well and reports no acute symptoms. Which of the following preventive interventions are indicated for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: 20-valent pneumococcal conjugate vaccine; Recombinant zoster vaccine

Answer

The indicated interventions are the 20-valent pneumococcal conjugate vaccine and the recombinant zoster vaccine.
This patient is immunocompromised due to maintenance infliximab (a TNF-alpha inhibitor) therapy for ulcerative colitis. Based on current guidelines, the recombinant zoster vaccine is recommended for all adults aged 19 years and older who are or will be immunodeficient or immunosuppressed. Additionally, adults aged 19 to 64 years with immunocompromising conditions require pneumococcal vaccination; the single-dose 20-valent pneumococcal conjugate vaccine (PCV20) is an indicated option for those with no prior pneumococcal vaccination history. Both of these vaccines are inactivated or recombinant and are safe to administer to patients on biologic therapy.

Step-by-Step Solution

1
Identify the patient's key demographic and clinical risk factors.
The patient is 46 years old, has a 25-pack-year smoking history, and is immunosuppressed (taking infliximab) for ulcerative colitis diagnosed 12 years ago.
Preventive guidelines are strictly stratified by age, immunosuppression status, and specific high-risk disease states.
2
Determine indicated vaccinations based on immune status.
Immunocompromised adults aged 19 and older require the recombinant zoster vaccine and pneumococcal vaccination (e.g., PCV20). Live vaccines (e.g., MMR) are contraindicated.
Biologic therapies like infliximab expand indications for certain inactivated/recombinant vaccines while creating absolute contraindications for live-attenuated vaccines.
3
Evaluate cancer screening eligibility based on age and underlying disease.
Lung cancer screening is not indicated until age 50. Colorectal screening is indicated due to age >45 and IBD duration >8 years, but requires colonoscopy rather than FIT.
Age cutoffs strictly govern lung cancer screening, while high-risk conditions dictate the specific modality required for colorectal screening.

Key Concept

Adults on immunosuppressive therapies require specific vaccinations (e.g., PCV20, RZV) starting at age 19 while strictly avoiding live vaccines, and high-risk disease states (like long-standing IBD) alter standard cancer screening modalities.
Question 4393Question →

A 32-year-old woman is evaluated in the clinic following a routine wellness examination that revealed an elevated serum calcium level. She has no complaints and reports feeling well. She has no history of nephrolithiasis, bone fractures, or abdominal pain. She takes no medications or over-the-counter supplements. Vital signs are normal. Physical examination is unremarkable.

Laboratory results are as follows:

Laboratory TestResultReference Range
Calcium, serum11.1 mg/dL8.4–10.2 mg/dL
Albumin, serum4.0 g/dL3.5–5.0 g/dL
Intact parathyroid hormone72 pg/mL10–65 pg/mL
25-hydroxyvitamin D34 ng/mL20–50 ng/mL
Creatinine, serum0.8 mg/dL0.6–1.2 mg/dL
Calcium, 24-hour urine60 mg/day100–300 mg/day

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Familial hypocalciuric hypercalcemia

Answer

Familial hypocalciuric hypercalcemia
The patient's laboratory results show mild hypercalcemia, mildly elevated intact parathyroid hormone (PTH), and significantly low 24-hour urine calcium excretion (<100 mg/day). This pattern is characteristic of familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant condition caused by an inactivating mutation in the calcium-sensing receptor (CaSR) in the parathyroid glands and kidneys. The defective receptor requires higher serum calcium levels to suppress PTH release, leading to inappropriately normal or mildly elevated PTH. In the kidneys, the defective receptor leads to increased tubular reabsorption of calcium, causing hypocalciuria. Differentiating FHH from primary hyperparathyroidism is critical because FHH is a benign condition that does not require parathyroidectomy.

Step-by-Step Solution

1
Analyze the serum calcium and PTH levels.
The patient has hypercalcemia (11.1 mg/dL) with an inappropriately elevated intact PTH level (72 pg/mL).
This establishes that the hypercalcemia is PTH-dependent, narrowing the differential to primary hyperparathyroidism, familial hypocalciuric hypercalcemia, or tertiary hyperparathyroidism.
2
Evaluate the 24-hour urine calcium excretion.
The patient has significant hypocalciuria (60 mg/day), which is well below the normal reference range.
This step is essential to differentiate between primary hyperparathyroidism (which typically features normal or high urine calcium) and familial hypocalciuric hypercalcemia.
3
Synthesize the findings to formulate a diagnosis.
The combination of hypercalcemia, mildly elevated PTH, and hypocalciuria points to familial hypocalciuric hypercalcemia.
The inactivating mutation in the calcium-sensing receptor causes both an increased set-point for PTH release and increased renal tubular calcium reabsorption.

Key Concept

Familial hypocalciuric hypercalcemia (FHH) presents with mild hypercalcemia, normal or slightly elevated parathyroid hormone (PTH), and significant hypocalciuria due to an inactivating mutation in the calcium-sensing receptor.
Question 4394Question →

Emergency medical services bring a 62-year-old gentleman to the trauma bay after he collapsed at home. His wife reports that he has been complaining of severe, unremitting abdominal pain for the past 48 hours. His past medical history includes long-standing osteoarthritis, for which he takes high-dose naproxen daily. On presentation, his temperature is 39.1°C (102.4°F), blood pressure is 82/50 mm Hg, pulse is 128/min, and respirations are 24/min. Physical examination reveals a distended, diffusely tender abdomen with rigid, board-like guarding and rebound tenderness. Bowel sounds are absent. An upright chest radiograph reveals free air under the right hemidiaphragm. Which of the following interventions are indicated immediately in this patient's management? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Transfer to the operating room for emergent exploratory laparotomy; Administration of intravenous crystalloids and broad-spectrum antibiotics

Answer

The correct interventions are the administration of intravenous crystalloids and broad-spectrum antibiotics, alongside immediate transfer to the operating room for an emergent exploratory laparotomy.
This patient presents with signs of septic shock and a rigid, acute abdomen. The presence of free air under the diaphragm on an upright chest radiograph confirms a hollow viscus perforation, highly likely to be a peptic ulcer given his heavy NSAID use. The standard of care for a perforated hollow viscus with peritonitis and hemodynamic instability requires concurrent life-saving measures: immediate medical resuscitation with intravenous fluids and broad-spectrum antibiotics to address the septic shock, and rapid transfer to the operating room for an exploratory laparotomy to achieve surgical source control.

Step-by-Step Solution

1
Interpret the clinical presentation and vital signs.
The patient has hypotension, tachycardia, and fever, indicating septic shock, accompanied by a rigid abdomen (peritonitis).
Recognizing the severity of the patient's instability dictates the urgency of intervention.
2
Correlate history with imaging findings.
Chronic NSAID use combined with free air under the diaphragm confirms a perforated hollow viscus, most likely a peptic ulcer.
Free intraperitoneal air in a patient without recent surgery represents a surgical emergency requiring source control.
3
Determine the appropriate sequencing of procedural interventions.
Simultaneous medical stabilization (fluids, antibiotics) and surgical exploration (laparotomy) are required.
Delays for further diagnostic testing in a hemodynamically unstable patient with an established acute abdomen increase mortality.

Key Concept

Management of a perforated hollow viscus with septic shock requires simultaneous medical resuscitation and emergent surgical exploration.
Question 4395Question →

A 35-year-old woman is brought to the emergency department by her husband due to severe agitation, confusion, and uncontrollable shivering that began abruptly earlier today. She has a history of treatment-resistant major depressive disorder. Ten days ago, her psychiatrist discontinued her fluoxetine regimen due to lack of efficacy. Three days ago, she was started on tranylcypromine. Her temperature is 39.2∘C39.2^\circ \text{C} (102.6∘F102.6^\circ \text{F}), blood pressure is 168/98 mm Hg168/98 \text{ mm Hg}, pulse is 128/min128/\text{min}, and respiratory rate is 22/min22/\text{min}. Physical examination reveals profuse diaphoresis, mydriasis, and hyperactive bowel sounds. Neurologic examination demonstrates severe lower extremity hyperreflexia and spontaneous clonus. Intravenous fluids and lorazepam are administered, but the patient remains highly agitated and her temperature increases to 39.8∘C39.8^\circ \text{C} (103.6∘F103.6^\circ \text{F}). Which of the following is the most appropriate next pharmacologic intervention?

Show answer & explanation

Answer: Administer cyproheptadine

Answer

The correct answer is to administer cyproheptadine.
The correct intervention is cyproheptadine. This patient is experiencing severe serotonin syndrome, precipitated by the premature initiation of tranylcypromine (a monoamine oxidase inhibitor) only 1010 days after discontinuing fluoxetine. Because fluoxetine and its active metabolite norfluoxetine have exceptionally long half-lives, a minimum 55-week washout period is required before starting an MAOI (compared to 22 weeks for other SSRIs). The diagnosis of serotonin syndrome is confirmed by the triad of altered mental status, autonomic instability (fever, diaphoresis, tachycardia), and neuromuscular hyperactivity (hyperreflexia, spontaneous clonus). When initial stabilization with intravenous fluids and benzodiazepines fails to control severe agitation and hyperthermia, the next step is the administration of cyproheptadine, a potent 5-HT2A receptor antagonist.

Step-by-Step Solution

1
Analyze the patient's medication history and recent changes.
The patient discontinued fluoxetine 1010 days ago and started tranylcypromine (an MAOI) 33 days ago.
Identifying recent medication changes is crucial for diagnosing toxidromes. Fluoxetine has an exceptionally long half-life and requires a minimum 55-week washout period before initiating an MAOI, unlike the 22-week washout required for other SSRIs.
2
Correlate the medication error with the clinical presentation.
The overlap of fluoxetine and tranylcypromine caused a massive accumulation of synaptic serotonin, leading to autonomic instability (fever, tachycardia), altered mental status, and neuromuscular hyperactivity (hyperreflexia, clonus).
This classic triad definitively diagnoses Serotonin Syndrome and differentiates it from other hyperthermic emergencies like Neuroleptic Malignant Syndrome (which presents with bradyreflexia and lead-pipe rigidity) or Anticholinergic Toxicity (which presents with dry skin and absent bowel sounds).
3
Determine the appropriate escalation of pharmacologic therapy.
Since the patient is failing initial supportive care and benzodiazepines (lorazepam) with worsening hyperthermia and agitation, a specific antidote is required.
Cyproheptadine is a first-generation antihistamine with potent serotonin (5-HT1A and 5-HT2A) antagonist properties, making it the definitive pharmacologic intervention for severe, benzodiazepine-refractory serotonin syndrome.

Key Concept

Management of Serotonin Syndrome and recognition of fluoxetine's extended washout period before MAOI initiation.
Question 4396Question →

A 29-year-old male is brought to the trauma center following a severe crush injury at a construction site. He is confused and pale. Vital signs are HR 142/min, BP 70/40 mm Hg, and RR 26/min. The airway is intact, and breath sounds are equal bilaterally. A focused assessment with sonography for trauma (FAST) exam shows no pericardial or intraperitoneal fluid. A portable chest radiograph is normal. A portable pelvic radiograph reveals a severe diastasis of the pubic symphysis and disruption of the right sacroiliac joint. A pelvic binder is immediately applied, and a massive transfusion protocol is initiated. After receiving 4 units of packed red blood cells, 4 units of fresh frozen plasma, and 1 unit of platelets over the next 20 minutes, the patient's blood pressure remains 72/42 mm Hg. The interventional radiology suite is currently occupied with another emergency, and the team will not be available for at least an hour. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate open preperitoneal pelvic packing

Answer

Immediate open preperitoneal pelvic packing is the correct management step for this actively exsanguinating patient.
The patient is in profound hemorrhagic shock secondary to an unstable pelvic fracture, which typically causes massive retroperitoneal venous bleeding. Because the FAST exam is negative (ruling out major intraperitoneal bleeding) and the patient remains hypotensive despite an appropriately placed pelvic binder and aggressive massive transfusion, definitive mechanical hemostasis is immediately required. With interventional radiology unavailable for angioembolization, open preperitoneal pelvic packing is the standard, life-saving surgical intervention to directly tamponade the bleeding retroperitoneal venous plexus.

Step-by-Step Solution

1
Identify the primary source of hemorrhagic shock.
The source is retroperitoneal bleeding from an unstable pelvic fracture.
The patient is hypotensive with a negative FAST exam and normal chest x-ray, making the severe pelvic ring disruption the definitive source of blood loss.
2
Evaluate the response to initial stabilization measures.
The patient remains in refractory shock despite the application of a pelvic binder and massive transfusion.
Ongoing venous plexus or arterial bleeding in the retroperitoneum has not been controlled by non-invasive external compression alone.
3
Determine the optimal definitive procedural intervention based on resource availability.
Proceed with open preperitoneal pelvic packing in the operating room.
Because interventional radiology is unavailable for an hour, surgical packing is the only immediate option to mechanically tamponade the retroperitoneal bleeding and prevent lethal exsanguination.

Key Concept

In a hemodynamically unstable patient with an isolated pelvic fracture and negative FAST, retroperitoneal hemorrhage is the primary concern. If angioembolization is unavailable or delayed, open preperitoneal pelvic packing is the immediate life-saving surgical intervention.
Question 4397Question →

A 72-year-old female patient with an established diagnosis of polymyalgia rheumatica is evaluated in the emergency department after noticing a sudden, painless loss of vision in her right eye two hours prior to arrival. During the interview, she notes experiencing new-onset right-sided jaw pain when chewing, along with fatigue and low-grade fevers over the preceding week. Visual acuity testing reveals light perception only in the right eye and 20/30 in the left eye. The right pupil exhibits a relative afferent pupillary defect. Fundoscopic examination of the right eye reveals a pale, opaque retina with a prominent cherry-red spot in the macula. Based on the complete clinical presentation and examination findings, arrange the following differential diagnoses for her acute vision loss from highest clinical probability to lowest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from highest to lowest clinical probability is: Central retinal artery occlusion, Arteritic anterior ischemic optic neuropathy, Rhegmatogenous retinal detachment, and Acute angle-closure glaucoma.
The correct sequence prioritizes the diagnoses by synthesizing both the patient's history and objective physical exam findings. Central retinal artery occlusion perfectly matches the fundoscopic findings of a pale retina and cherry-red spot in the setting of suspected giant cell arteritis. Arteritic anterior ischemic optic neuropathy is the next most likely as it matches the systemic history but not the fundus exam. Retinal detachment is less likely as it lacks the systemic symptoms and exam findings, and acute angle-closure glaucoma is least likely because it directly contradicts the painless presentation.

Step-by-Step Solution

1
Analyze the chief complaint and vital signs.
The patient has sudden, painless unilateral vision loss.
This immediately categorizes the differential into vascular, neuropathic, or structural retinal causes, while moving painful causes lower on the differential.
2
Integrate the past medical history and review of systems.
The history of polymyalgia rheumatica, jaw claudication, and fevers points strongly to giant cell (temporal) arteritis as the underlying etiology.
Identifying the underlying systemic disease narrows the highest-probability diagnoses to complications of giant cell arteritis.
3
Evaluate the objective physical exam findings.
The fundoscopic exam shows a pale retina with a cherry-red spot.
This is the pathognomonic physical exam finding for a central retinal artery occlusion, differentiating it from other causes of painless vision loss.
4
Prioritize the differential diagnoses.
Central retinal artery occlusion is most likely. Arteritic anterior ischemic optic neuropathy is second (matches history, fails exam). Retinal detachment is third (matches only the chief complaint). Angle-closure glaucoma is last (contradicts the painless presentation).
Differential diagnoses must be ordered by how comprehensively they account for the history, symptoms, and objective physical exam findings.

Key Concept

Formulating a differential diagnosis for acute vision loss requires integrating systemic risk factors (such as symptoms of giant cell arteritis) with objective fundoscopic examination findings.
Question 4398Question →

A 66-year-old man is brought to the emergency department by his wife due to a 3-day history of progressively worsening shortness of breath, increased cough, and a change in his sputum from clear to thick, dark yellow. He has a 40-pack-year smoking history and was diagnosed with chronic obstructive pulmonary disease (COPD) five years ago. His home medications include a once-daily umeclidinium-vilanterol inhaler and an albuterol rescue inhaler, which he has used eight times today with minimal relief. He has no other major medical conditions. Temperature is 37.8°C (100.0°F), blood pressure is 146/88 mmHg, pulse is 114/min, and respiratory rate is 26/min. Pulse oximetry shows 88% on room air. The patient is using accessory muscles of respiration. Physical examination reveals a barrel-shaped chest, a prolonged expiratory phase, and diffuse bilateral wheezing. There is no jugular venous distention or lower extremity edema. A chest radiograph reveals hyperinflation without focal consolidation, pneumothorax, or pleural effusion.

Which of the following pharmacologic interventions should be included in the immediate management of this patient? (Select all that apply, indicating hangileri doğrudur)

Select all that apply

Show answer & explanation

Answer: Inhaled albuterol and ipratropium; Oral prednisone; Oral azithromycin

Answer

The correct interventions are inhaled albuterol and ipratropium, oral prednisone, and oral azithromycin.
The correct options represent the triad of standard care for acute exacerbations of COPD (AECOPD). The patient presents with all three cardinal symptoms (increased dyspnea, increased sputum volume, and increased sputum purulence), which strongly indicates the need for antibiotics. Therefore, the combination of short-acting bronchodilators (inhaled albuterol and ipratropium) to provide rapid airway smooth muscle relaxation, systemic glucocorticoids (oral prednisone) to decrease airway inflammation and edema, and a macrolide antibiotic (oral azithromycin) to target common respiratory pathogens (including S. pneumoniae, H. influenzae, and M. catarrhalis) constitutes the optimal immediate pharmacologic strategy.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has progressively worsened dyspnea, increased sputum volume, increased sputum purulence, hypoxia, and diffuse wheezing.
To accurately diagnose an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and determine its severity based on the cardinal symptoms.
2
Determine the necessary classes of pharmacologic interventions for AECOPD.
Standard management requires the triad of short-acting bronchodilators, systemic corticosteroids, and (due to the presence of purulent sputum) antibiotics.
To acutely reverse airflow obstruction, reduce airway inflammation, and treat underlying bacterial triggers contributing to the exacerbation.
3
Evaluate the specific medication choices provided in the options.
Select albuterol/ipratropium (bronchodilators), prednisone (corticosteroid), and azithromycin (antibiotic with good S. pneumoniae coverage). Reject propranolol and ciprofloxacin.
Propranolol is strictly contraindicated due to the risk of worsening bronchospasm. Ciprofloxacin is inappropriate due to insufficient coverage of Streptococcus pneumoniae.

Key Concept

The acute management of COPD exacerbations relies on three main pharmacologic pillars: short-acting bronchodilators, systemic glucocorticoids, and appropriate empiric antibiotics (when sputum purulence is present) that cover common respiratory pathogens. Interventions that exacerbate bronchospasm must be strictly avoided.
Question 4399Question →

An 82-year-old woman is evaluated for discharge planning. She was admitted to the hospital 11 days ago for severe community-acquired pneumonia. Upon admission, she had a CURB-65 score of 4, requiring intubation and a 7-day stay in the intensive care unit. She was successfully extubated 4 days ago and transferred to the general medical ward.

Currently, she is awake, alert, and oriented. She reports feeling much better but is profoundly fatigued. Temperature is 37.1°C (98.8°F), blood pressure is 128/76 mm Hg, pulse is 78/min, and respirations are 16/min. Pulse oximetry is 96% on room air. Lungs are clear to auscultation bilaterally.

Laboratory studies show a leukocyte count of 11,200/mm³, decreased from a peak of 24,000/mm³ on admission. Her renal function and electrolytes are within normal limits. She is currently completing a 14-day course of oral antibiotics.

Prior to admission, the patient lived at home with her 84-year-old husband and was independent with all activities of daily living. Currently, she has profound generalized muscle weakness consistent with ICU-acquired weakness. She requires the maximal assistance of two people to transfer from the bed to a chair and cannot feed herself or perform basic grooming. Physical and occupational therapy evaluate her and note that she has excellent potential for functional recovery; however, she completely exhausts after 30 minutes of mild therapeutic exercise and is unable to participate in more intensive therapy sessions at this time.

Her husband, who uses a wheelchair due to severe osteoarthritis, is unable to assist with her physical care. They have no other family members nearby.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility (SNF)

Answer

Transfer to a skilled nursing facility (SNF)
The most appropriate disposition for this patient is a transfer to a skilled nursing facility (SNF). This patient is medically stable and ready for discharge from the acute care hospital, but she has significant functional deficits due to prolonged intubation and ICU-acquired weakness. She requires maximum assistance for transfers and activities of daily living, making a home discharge unsafe, especially given that her husband uses a wheelchair and cannot provide physical assistance. While she has excellent rehabilitation potential, she completely exhausts after 30 minutes of therapy. An inpatient rehabilitation facility (IRF) mandates that patients can tolerate at least 3 hours of intensive therapy per day. Because she cannot currently meet this threshold, an SNF is the ideal setting. SNFs provide 24/7 skilled nursing care, assistance with basic ADLs, and rehabilitation services at a less intensive, more tolerable pace.

Step-by-Step Solution

1
Assess the patient's current medical stability and acute care needs.
The patient is hemodynamically stable, off oxygen, and only requires oral antibiotics. She no longer meets criteria for acute inpatient care.
To determine if continued acute hospitalization is medically warranted.
2
Evaluate the patient's functional status and rehabilitation potential.
The patient has severe ICU-acquired weakness and requires maximum assistance for transfers. While she has excellent recovery potential, she exhausts after 30 minutes of therapy.
To determine the appropriate level of post-acute rehabilitation intensity.
3
Assess the patient's home social support and safety.
Her husband is wheelchair-bound and cannot assist with her significant physical needs, making home discharge unsafe even with intermittent home health services.
To determine if home-based care is a viable and safe option.
4
Match the patient's clinical and functional profile to the correct post-acute care setting.
A skilled nursing facility (SNF) is selected because it provides necessary 24/7 custodial care and a tolerable pace of rehabilitation, unlike an IRF which requires 3 hours of daily therapy.
To ensure safe and effective transition of care according to established disposition criteria.

Key Concept

Patients with significant functional impairment and rehabilitation potential who cannot tolerate 3 hours of intensive daily therapy should be dispositioned to a skilled nursing facility (SNF) rather than an inpatient rehabilitation facility (IRF).
Question 4400Question →

Following a heavy dinner, a 41-year-old female is brought to the emergency department by her partner due to sudden, unremitting right upper abdominal pain radiating to the right scapula. She reports intense nausea and has vomited twice over the past few hours. She is a non-smoker with a BMI of 34 kg/m² and a history of hypertriglyceridemia. Upon triage, her temperature is 38.5°C (101.3°F), pulse is 112/min, blood pressure is 135/85 mm Hg, and respiratory rate is 18/min. Abdominal examination demonstrates focal tenderness below the right costal margin, which sharply worsens on deep inspiration, causing her to abruptly halt her breath. There are no signs of clinical jaundice. To properly evaluate this patient's acute presentation, which of the following are the most appropriate initial diagnostic tests to order? (Select exactly 3 options)

Select all that apply

Show answer & explanation

Answer: Right upper quadrant abdominal ultrasound; Complete blood count; Hepatic function panel

Answer

The correct initial diagnostic tests are a right upper quadrant abdominal ultrasound, a complete blood count, and a hepatic function panel.
This patient's presentation of postprandial right upper quadrant pain, fever, and a positive Murphy sign is classic for acute cholecystitis. The most appropriate initial diagnostic workup consists of a right upper quadrant abdominal ultrasound, a complete blood count (CBC), and a hepatic function panel. Ultrasound is the imaging modality of choice due to its high sensitivity and specificity for identifying gallstones, gallbladder wall thickening, and pericholecystic fluid, without exposing the patient to ionizing radiation. A CBC is required to evaluate for leukocytosis, which supports an infectious or inflammatory process. A hepatic function panel (including transaminases, bilirubin, and alkaline phosphatase) is essential to evaluate for potential biliary obstruction (choledocholithiasis) or ascending cholangitis, which would significantly alter subsequent management.

Step-by-Step Solution

1
Analyze the clinical presentation and vital signs.
The patient exhibits signs of systemic inflammation (fever, tachycardia) and localized right upper quadrant findings (positive Murphy sign) that are highly suspicious for acute cholecystitis.
Establishing the most likely working diagnosis determines the immediate sequence of diagnostic testing.
2
Determine the optimal first-line imaging modality.
Right upper quadrant abdominal ultrasound is identified as the best imaging step.
Ultrasound is the most sensitive, specific, non-invasive, and cost-effective initial test for detecting gallstones and signs of gallbladder inflammation.
3
Identify the necessary initial laboratory investigations.
A complete blood count and a hepatic function panel are selected to accompany the imaging.
These labs assess the severity of the infection (leukocytosis) and check for biliary tree obstruction (elevated transaminases, bilirubin, or alkaline phosphatase), which would alter downstream management.

Key Concept

In patients with suspected acute cholecystitis, the standard initial diagnostic workup involves a right upper quadrant abdominal ultrasound combined with a complete blood count and hepatic function panel to confirm the diagnosis and screen for complications.
PreviousPage 220 / 237Next
All practice questions — USMLE Step 3 | Examkin